![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ogawa Setsuro
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.10, 2012-10, pp. : 793-806
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pregabalin or morphine and gabapentin for neuropathic pain
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Randomized Controlled Trials and Assessment of Drug Safety
Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pregabalin improves on usual care in neuropathic pain
Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Flexible-, fixed-dose pregabalin reduces neuropathic pain
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :